Denali Therapeutics Inc. Common Stock DNLI

$24.82 -1.78% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-14 View →
4 FORM 4 2026-08-13 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
8-K 8-K 2026-07-28 View →
8-K 8-K 2026-06-18 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 4 2026-06-05 View →
8-K 8-K 2026-06-04 View →
8-K 8-K 2026-05-22 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-21 View →
8-K 8-K 2026-04-03 View →
8-K 8-K 2026-03-31 View →
8-K 8-K 2026-03-25 View →
10-K 10-K 2026-02-26 View →
8-K 8-K 2026-02-26 View →
4 FORM 4 2026-01-08 View →
4 FORM 4 2026-01-08 View →
8-K 8-K 2026-01-06 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 4 2025-12-15 View →
8-K 8-K 2025-12-10 View →
424B5 424B5 2025-12-10 View →
424B5 424B5 2025-12-09 View →
8-K 8-K 2025-12-04 View →
8-K 8-K 2025-12-04 View →
4 FORM 4 2025-11-06 View →
10-Q 10-Q 2025-11-06 View →
8-K 8-K 2025-11-06 View →
8-K 8-K 2025-10-14 View →
4 FORM 4 2025-09-05 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$24.82
Market Cap
$4.04 billion
52-Week Range
$12.58 – $27.30
Average Volume
1.65 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.